ANIX
Anixa BiosciencesยทNASDAQ
--
--(--)
--
--(--)
ANIX Profile
Anixa Biosciences, Inc.
A biotechnology company focused on the treatment and prevention of cancer and infectious diseases
3150 Almaden Expressway, Suite 250, San Jose, CA 95118
--
Anixa Biosciences, Inc., a biotechnology company incorporated under the laws of the State of Delaware on November 5, 1982, is dedicated to the development of innovative therapies and vaccines that address key unmet needs in the field of oncology. The company's therapeutic program centers on the development of liraltagene autoleucel (lira-cel), a chimeric endocrine receptor T-cell therapy that represents an advanced form of CAR-T technology, currently being developed by its subsidiary, Certainty Therapeutics, Inc., with an initial focus on ovarian cancer. In addition, Anixa's vaccine program includes the development of vaccines against breast and ovarian cancer, as well as an exploratory program aimed at applying similar mechanisms to develop other cancer vaccines against organ malignancies such as lung, colon and prostate cancers.
